One-Month TB prevention pill could beat Three-Month regimen in High-Risk groups
NCT ID NCT05118490
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tests if a one-month daily TB prevention treatment works as well as a three-month weekly one in people with HIV and in HIV-negative household contacts of TB patients. The goal is to see which approach leads to better treatment completion and fewer side effects. About 1,000 participants in South Africa and India are involved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundação Aurum (The Aurum Institute Mozambique)
Chokwé, Gaza Province, Mozambique
-
The Aurum Institute: Gavin J Churchyard Legacy Centre
Klerksdorp, North West, 2571, South Africa
-
The Byramjee Jeejeebhoy Medical Centre (BJGMC-JHU) CRS
Pune, Maharashtra, 411001, India
-
Yayasan KNCV - The Persahabatan Hospital, Jakarta
Jakarta, Jaya, 14350, Indonesia
Conditions
Explore the condition pages connected to this study.